Semaglutide: The GLP-1 Receptor Agonist Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist
Yes, regular lipid profile monitoring remains essential for patients with known dyslipidaemia or cardiovascular risk factors
Amid growing awareness that obesity is a chronic biological, and therefore treatable, disease, bariatric surgery volumes steadily increased from 158,000 people in 2011 to 280,000 in 2022, according to the American Society for Metabolic and Bariatric Surgery
It helps to bind to toxins and make them more water-soluble, allowing the body to excrete them more easily
At SLC Med Spa , we offer physician-supervised medical weight loss programs in Utah using GLP-1 medications combined with personalized nutrition coaching to help patients achieve lasting results
2021;23(Suppl 1):316